Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

202 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

3 Mid-Cap Stocks with Warning Signs

By: StockStory

February 25, 2026 at 23:41 PM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

OSK Cover Image

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.

This is precisely where StockStory comes in - we do the heavy lifting to identify companies with solid fundamentals so you can invest with confidence. Keeping that in mind, here are three mid-cap stocks to swipe left on and some alternatives you should look into instead.

Oshkosh (OSK)

Market Cap: $10.78 billion

Oshkosh (NYSE: OSK) manufactures specialty vehicles for the defense, fire, emergency, and commercial industry, operating various brand subsidiaries within each industry.

Why Are We Hesitant About OSK?

Demand cratered as it couldn’t win new orders over the past two years, leading to an average 5.7% decline in its backlog
Gross margin of 16.5% is below its competitors, leaving less money to invest in areas like marketing and R&D
Earnings growth over the last two years fell short of the peer group average as its EPS only increased by 4.5% annually

At $172.39 per share, Oshkosh trades at 15.7x forward P/E. Read our free research report to see why you should think twice about including OSK in your portfolio.

Centene (CNC)

Market Cap: $20.99 billion

Serving nearly 1 in 15 Americans through its government healthcare programs, Centene (NYSE: CNC) is a healthcare company that manages government-sponsored health insurance programs like Medicaid and Medicare for low-income and complex-needs populations.

Why Does CNC Fall Short?

Customer growth was choppy over the past two years, suggesting that increasing competition is causing challenges in landing new contracts
Incremental sales over the last five years were much less profitable as its earnings per share fell by 16.3% annually while its revenue grew
Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results

Centene’s stock price of $42.78 implies a valuation ratio of 13.9x forward P/E. Dive into our free research report to see why there are better opportunities than CNC.

West Pharmaceutical Services (WST)

Market Cap: $17.85 billion

Founded in 1923 and serving as a critical link in the pharmaceutical supply chain, West Pharmaceutical Services (NYSE: WST) manufactures specialized packaging, containment systems, and delivery devices for injectable drugs and healthcare products.

Why Does WST Give Us Pause?

Muted 2.1% annual revenue growth over the last two years shows its demand lagged behind its healthcare peers
Expenses have increased as a percentage of revenue over the last five years as its adjusted operating margin fell by 6.7 percentage points
Diminishing returns on capital suggest its earlier profit pools are drying up

West Pharmaceutical Services is trading at $247.92 per share, or 30.7x forward P/E. If you’re considering WST for your portfolio, see our FREE research report to learn more.

High-Quality Stocks for All Market Conditions

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	265.57	-0.25 (-0.09%)
AAPL	295.35	+0.55 (0.19%)
AMD	436.44	-11.85 (-2.64%)
BAC	50.68	-0.10 (-0.20%)
GOOG	389.64	+5.82 (1.52%)
META	606.83	+3.83 (0.63%)
MSFT	404.30	-3.47 (-0.85%)
NVDA	224.45	+3.67 (1.66%)
ORCL	190.58	+3.75 (2.01%)
TSLA	438.83	+5.38 (1.24%)